Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 149

    1.

    A consensus prognostic gene expression classifier for ER positive breast cancer.

    Teschendorff AE, Naderi A, Barbosa-Morais NL, Pinder SE, Ellis IO, Aparicio S, Brenton JD, Caldas C.

    Genome Biol. 2006;7(10):R101. Epub 2006 Oct 31.

    PMID:
    17076897
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    A gene-expression signature to predict survival in breast cancer across independent data sets.

    Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, Powe DG, Robertson JF, Aparicio S, Ellis IO, Brenton JD, Caldas C.

    Oncogene. 2007 Mar 1;26(10):1507-16. Epub 2006 Aug 28.

    PMID:
    16936776
    [PubMed - indexed for MEDLINE]
    3.

    An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.

    Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C.

    Genome Biol. 2007;8(8):R157.

    PMID:
    17683518
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Challenges in projecting clustering results across gene expression-profiling datasets.

    Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

    J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23. Epub 2007 Nov 13.

    PMID:
    18000217
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    The molecular portraits of breast tumors are conserved across microarray platforms.

    Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM.

    BMC Genomics. 2006 Apr 27;7:96.

    PMID:
    16643655
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.

    Martin KJ, Patrick DR, Bissell MJ, Fournier MV.

    PLoS One. 2008 Aug 20;3(8):e2994.

    PMID:
    18714348
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.

    Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ.

    PLoS One. 2009;4(3):e4710. Epub 2009 Mar 9.

    PMID:
    19270750
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.

    Calabrò A, Beissbarth T, Kuner R, Stojanov M, Benner A, Asslaber M, Ploner F, Zatloukal K, Samonigg H, Poustka A, Sültmann H.

    Breast Cancer Res Treat. 2009 Jul;116(1):69-77. Epub 2008 Jul 1.

    PMID:
    18592372
    [PubMed - indexed for MEDLINE]
    9.

    Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.

    Gruvberger-Saal SK, Edén P, Ringnér M, Baldetorp B, Chebil G, Borg A, Fernö M, Peterson C, Meltzer PS.

    Mol Cancer Ther. 2004 Feb;3(2):161-8.

    PMID:
    14985456
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

    Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.

    Breast Cancer Res. 2008;10(5):R88. Epub 2008 Oct 17.

    PMID:
    18928543
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

    Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

    Breast Cancer Res. 2007;9(5):R59.

    PMID:
    17850661
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.

    Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidone MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C.

    BMC Genomics. 2008 May 22;9:239.

    PMID:
    18498629
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer.

    Rody A, Karn T, Ruckhäberle E, Müller V, Gehrmann M, Solbach C, Ahr A, Gätje R, Holtrich U, Kaufmann M.

    Breast Cancer Res Treat. 2009 Feb;113(3):457-66. Epub 2008 Mar 14.

    PMID:
    18340528
    [PubMed - indexed for MEDLINE]
    14.

    Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.

    Smith DD, Saetrom P, Snøve O Jr, Lundberg C, Rivas GE, Glackin C, Larson GP.

    BMC Bioinformatics. 2008 Jan 28;9:63.

    PMID:
    18226260
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

    Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M.

    Breast Cancer Res. 2009;11(2):R15. Epub 2009 Mar 9.

    PMID:
    19272155
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.

    Tebbit CL, Zhai J, Untch BR, Ellis MJ, Dressman HK, Bentley RC, Baker JA, Marcom PK, Nevins JR, Marks JR, Olson JA Jr.

    Breast Cancer Res Treat. 2009 Dec;118(3):635-43. Epub 2009 Feb 18.

    PMID:
    19224362
    [PubMed - indexed for MEDLINE]
    17.

    Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

    Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

    Breast Cancer Res. 2008;10(4):R65. Epub 2008 Jul 28.

    PMID:
    18662380
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Identification of a robust gene signature that predicts breast cancer outcome in independent data sets.

    Korkola JE, Blaveri E, DeVries S, Moore DH 2nd, Hwang ES, Chen YY, Estep AL, Chew KL, Jensen RH, Waldman FM.

    BMC Cancer. 2007 Apr 11;7:61.

    PMID:
    17428335
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer.

    Schneider J, Ruschhaupt M, Buness A, Asslaber M, Regitnig P, Zatloukal K, Schippinger W, Ploner F, Poustka A, Sültmann H.

    Int J Cancer. 2006 Dec 15;119(12):2974-9.

    PMID:
    17019712
    [PubMed - indexed for MEDLINE]
    20.

    TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.

    Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS.

    Breast Cancer Res. 2007;9(3):R30.

    PMID:
    17504517
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk